Literature DB >> 18584284

Some lessons from the tissue transglutaminase knockout mouse.

Z Sarang1, B Tóth, Z Balajthy, K Köröskényi, E Garabuczi, L Fésüs, Z Szondy.   

Abstract

Transglutaminase 2 (TG2) is an inducible transamidating acyltransferase that catalyzes Ca(2+)-dependent protein modifications. It acts as a G protein in transmembrane signaling and as a cell surface adhesion mediator, this distinguishes it from other members of the transglutaminase family. The sequence motifs and domains revealed in the TG2 structure, can each be assigned distinct cellular functions, including the regulation of cytoskeleton, cell adhesion, and cell death. Though many biological functions of the enzyme have already been described or proposed previously, studies of TG2 null mice by our laboratory during the past years revealed several novel in vivo roles of the protein. In this review we will discuss these novel roles in their biological context.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584284     DOI: 10.1007/s00726-008-0130-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  18 in total

1.  In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.

Authors:  Miho Itoh; Tadafumi Kawamoto; Hideki Tatsukawa; Soichi Kojima; Kiyofumi Yamanishi; Kiyotaka Hitomi
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

2.  Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.

Authors:  Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic development.

Authors:  Miho Itoh; Hideki Tatsukawa; Lee Eun-Seo; Kiyofumi Yamanishi; Soichi Kojima; Kiyotaka Hitomi
Journal:  J Histochem Cytochem       Date:  2013-07-29       Impact factor: 2.479

4.  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Zachary Herrera; Megan Albertelli; Chaitan Khosla
Journal:  J Med Chem       Date:  2014-10-31       Impact factor: 7.446

Review 5.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 6.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 7.  Role of transglutaminase 2 in celiac disease pathogenesis.

Authors:  Cornelius Klöck; Thomas R Diraimondo; Chaitan Khosla
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

8.  Intracellular TG2 Activity Increases Microtubule Stability but is not Sufficient to Prompt Neurite Growth.

Authors:  Shunling Guo; Brad A Palanski; Cornelius Kloeck; Chaitan Khosla; Bianxiao Cui
Journal:  Neurosci Bull       Date:  2016-11-04       Impact factor: 5.203

Review 9.  Post-translational modifications of tubulin: pathways to functional diversity of microtubules.

Authors:  Yuyu Song; Scott T Brady
Journal:  Trends Cell Biol       Date:  2014-11-25       Impact factor: 20.808

10.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.